Clinical Trial Update: Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study [Phase 2]

View source ↗

Summary

Phase 2 study using the PET tracer 18F-FDOPA in high-grade glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• 18F-FDOPA (fluorodopa (18F))

Snippet

Sponsor: Alan Nichol | Conditions: Cancer (High-grace Glioma) | Phase 2 | Status: COMPLETED